4-(1H-吲哚-3-基)丁胺 | 669-70-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 4-(1H-吲哚-3-基)丁胺
• 英文名称: 3-(4-aminobutyl)indole
• 英文别名: 4-(indol-3-yl)butan-1-amine；1H-indole-3-butanamine；4-(1H-indol-3-yl)-butylamine；4-indol-3-yl-butylamine；4-(1H-indol-3-yl)butan-1-amine
• CAS: 669-70-5
• 化学式: C₁₂H₁₆N₂
• mdl: MFCD20311166
• 分子量: 188.272
• InChiKey: GZQBGZWAALHNBW-UHFFFAOYSA-N

物化性质

• 沸点：
  377.3±25.0 °C(Predicted)
• 密度：
  1.098±0.06 g/cm3(Predicted)
• 熔点：
  51-53 °C

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  41.8
• 氢给体数：
  2
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  4-(1H-吲哚-3-基)丁胺 在 sodium hydroxide 、 羟胺 、 sodium cyanoborohydride 作用下， 以 甲醇 为溶剂， 生成 (E)-N-Hydroxy-3-(4-{[4-(1H-indol-3-yl)-butylamino]-methyl}-phenyl)-acrylamide
  参考文献：
  名称：

  N-Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity:  Discovery of (2E)-N-Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)

  摘要：

  A series of N-hydroxy-3-phenyl-2-propenamides were prepared as novel inhibitors of human histone deacetylase (HDAC). These compounds were potent enzyme inhibitors, having IC(50)s < 400 nM in a partially purified enzyme assay. However, potency in cell growth inhibition assays ranged over 2 orders of magnitude in two human carcinoma cell lines. Selected compounds having cellular IC50 < 750 nM were tested for maximum tolerated dose (MTD) and for efficacy in the HCT116 human colon tumor xenograft assay. Four compounds having an MTD 100 mg/kg were selected for dose-response studies in the HCT116 xenograft model. One compound, 9 (NVP-LAQ824), had significant dose-related activity in the HCT116 colon and A549 lung tumor models, high MTD, and low gross toxicity. On the basis, in part, of these properties, 9 has entered human clinical trials in 2002.

  DOI：

  10.1021/jm030235w
• 作为产物：
  描述：

  4-(吲哚-3-基)丁酸甲酯 在 lithium aluminium tetrahydride 、 氨 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 72.0h， 生成 4-(1H-吲哚-3-基)丁胺
  参考文献：
  名称：

  Intramolecular Mannich Reaction of 2-Oxotryptamine and Homologues with Oxo Reagents Yielding Spiro Compounds. Part II

  摘要：

  2-氧代色胺及其同系物通过与丙酮和其他酮发生分子内Mannich型环化反应，得到螺[吲哚-3,3'-吡咯啉]-2-酮和螺[吲哚-3,3'-哌啶]-2-酮。对2-氧代色胺的双同系物进行类似反应以获得螺[环庚烷-3,3'-吲哚]-2'-酮的尝试未成功。

  DOI：

  10.1135/cccc20021669

文献信息

• Unified Synthesis of Polycyclic Alkaloids by Complementary Carbonyl Activation**
  作者：Guoli He、Benjamin List、Mathias Christmann

  DOI：10.1002/anie.202102518

  日期：2021.6.7

  A complementary dual carbonyl activation strategy for the synthesis of polycyclic alkaloids has been developed. Successful applications include the synthesis of tetracyclic alkaloids harmalanine and harmalacinine, pentacyclic indoloquinolizidine alkaloid nortetoyobyrine, and octacyclic β-carboline alkaloid peganumine A. The latter synthesis features a protecting-group-free assembly and an asymmetric

  已经开发出用于合成多环生物碱的互补双羰基活化策略。成功的应用包括四环生物碱骆驼蓬菌素和骆驼蓬菌素、五环吲哚喹啉西啶生物碱去甲代拜林和八环β-咔啉生物碱peganumine A的合成。后者的合成具有无保护基组装和不对称二磺酰亚胺催化环化的特点。此外，还实现了 hirsutine、deplancheine、10-desbromoarborescidine A 和 oxindole 生物碱钩藤碱和异钩藤碱的正式合成。最终完成了小檗碱生物碱ilicifoline B的简捷合成。
• ORGANIC COMPOUNDS
  申请人：ANG Shi Hua

  公开号：US20090275560A1

  公开（公告）日：2009-11-05

  The invention relates to organic compounds which have interesting pharmaceutical properties. In particular, the compounds are useful in the treatment and/or prevention of infections such as those caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, Trypanosoma cruzi and parasites of the Leishmania genus such as, for example, Leishmania donovani . The invention also relates to pharmaceutical compositions containing the compounds, as well as processes for their preparation.

  这项发明涉及具有有趣药理特性的有机化合物。具体来说，这些化合物在治疗和/或预防由疟原虫、间日疟原虫、疟原虫、卵形疟原虫、克氏锥虫等引起的感染方面具有用途，以及像唐氏锥虫属的寄生虫，例如唐氏锥虫等。该发明还涉及含有这些化合物的药物组合物，以及它们的制备方法。
• Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria
  作者：Bryan K. S. Yeung、Bin Zou、Matthias Rottmann、Suresh B. Lakshminarayana、Shi Hua Ang、Seh Yong Leong、Jocelyn Tan、Josephine Wong、Sonja Keller-Maerki、Christoph Fischli、Anne Goh、Esther K. Schmitt、Philipp Krastel、Eric Francotte、Kelli Kuhen、David Plouffe、Kerstin Henson、Trixie Wagner、Elizabeth A. Winzeler、Frank Petersen、Reto Brun、Veronique Dartois、Thierry T. Diagana、Thomas H. Keller

  DOI：10.1021/jm100410f

  日期：2010.7.22

  Racemic spiroazepineindole (1) was identified from a phenotypic screen on wild type Plasmodium falciparum with an in vitro IC(50) of 90 nM. Structure-activity relationships for the optimization of 1 to compound 20a (IC(50) = 0.2 nM) including the identification of the active 1R,3S enantiomer and elimination of metabolic liabilities is presented. Improvement of the pharmacokinetic profile of the series translated

  描述了一系列螺四氢 β-咔啉的抗疟原虫活性。外消旋螺氮杂吲哚 (1) 是从野生型恶性疟原虫的表型筛选中鉴定出来的，体外 IC(50) 为 90 nM。介绍了优化 1 到化合物 20a (IC(50) = 0.2 nM) 的构效关系，包括识别活性 1R、3S 对映异构体和消除代谢负担。该系列药代动力学特征的改进在伯氏疟原虫感染的疟疾小鼠模型中转化为卓越的口服功效，在该模型中，五只小鼠中有四只每天服用 30 毫克/千克的剂量，完全治愈。
• [DE] SUBSTITUIERTE CYCLOHEXYLESSIGSÄURE-DERIVATE<br/>[EN] SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES<br/>[FR] DERIVES D'ACIDE CYCLOHEXYLE-ACETIQUE SUBSTITUES
  申请人：GRUENENTHAL GMBH

  公开号：WO2005110976A1

  公开（公告）日：2005-11-24

  Die vorliegende Erfindung betrifft substituierte Cyclohexylessigsäure-Derivate, Verfahren zu deren Herstellung, Arzneimittel enthaltend diese Verbindungen und die Verwendung von substituierten Cyclohexylessigsäure-Derivaten zur Herstellung von Arzneimitteln.

  本发明涉及取代环己基乙酸衍生物，其制备方法，含有这些化合物的药物，以及利用取代环己基乙酸衍生物制备药物的用途。
• Indol-2-one Intermediates:  Mechanistic Evidence and Synthetic Utility. Total Syntheses of (±)-Flustramines A and C
  作者：James R. Fuchs、Raymond L. Funk

  DOI：10.1021/ol047532v

  日期：2005.2.1

  A variety of 3,3-disubstituted 2-indolinones have been prepared by treatment of 3-bromo-3-alkyl-2-indolinones with dienophiles/nucleophiles in the presence of cesium carbonate. Application of this general strategy has facilitated the total syntheses of the reverse prenylated marine natural products (+/-)-flustramine A and (+/-)-flustramine C. [Structure: see text]

  通过在碳酸铯存在下用亲二烯体/亲核试剂处理3-溴-3-烷基-2-吲哚酮制备了各种3，3-二取代的2-吲哚酮。该通用策略的应用促进了反向异戊酸酯化的海洋天然产物（+/-）-氟链胺A和（+/-）-氟链胺C的总合成。[结构：参见文本]